Portfolio company
VenoStent
United States · £15.8m raised
Raised
£15.8m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
SourceFunding history · 1
Similar companies
Laminate Medical Technologies
This company develops an external support device to improve fistula success for hospitals and clinicians treating patients requiring dialysis.
XS Innovations
This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.
Healionics
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
Auvi Labs
This company develops a wearable ultrasound patch to monitor dialysis access and detect potential fistula failure for patients and clinicians.
Sonavex
This medical technology company develops automated ultrasound devices and bioresorbable markers for dialysis clinics and surgical teams to monitor vascular access and blood flow.
STENTiT
The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
